Clinical Trial Update: Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder [Phase 2]

View source ↗

Summary

Phase 2 study evaluating tolterodine, pregabalin, and a tolterodine-pregabalin combination for treating overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Pregabalin (Pregabalin)
• Tolterodine (tolterodine)
• Tolterodine - Pregabalin combination

Snippet

Sponsor: Pfizer | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED